COPI (coat protein I) and the clathrin-AP-2 (adaptor protein 2) complex are well-characterized coat proteins, but a component that is common to these two coats has not been identified. The GTPase-activating protein (GAP) for ADP-ribosylation factor 1 (ARF1), ARFGAP1, is a known component of the COPI complex. Here, we show that distinct regions of ARFGAP1 interact with AP-2 and coatomer (components of the COPI complex). Selectively disrupting the interaction of ARFGAP1 with either of these two coat proteins leads to selective inhibition in the corresponding transport pathway. The role of ARFGAP1 in AP-2-regulated endocytosis has mechanistic parallels with its roles in COPI transport, as both its GAP activity and coat function contribute to promoting AP-2 transport.
Interactions with ARFGAP1 and effects of its knockdown. (a) Detection of proteins interacting with ARFGAP1 using a GST-pulldown assay. GST-ARFGAP1 was incubated with cytosol and associated proteins were analysed by Coomassie blue staining. (b) Detection of ARFGAP1 interactions with coat components using a GST-pulldown assay. GST-ARFGAP1 was incubated with cytosol and immunoblotted for the indicated proteins. ARFGAP1 interacts with components of AP-2, and also with previously known interacting proteins that are components of the COPI complex. CHC, clathrin heavy chain. (c) Tf uptake is reduced by siRNA against ARFGAP1. BSC-1 cells were bound with fluorescently labelled Tf and assessed for the level of internalized Tf at 10 min. The mean from three experiments with standard error is shown. The difference between the two conditions is significant (P < 0.05). (d) EGF uptake is not markedly affected by siRNA against ARFGAP1. BSC-1 cells were bound with fluorescently labelled EGF and assessed for the level of internalized EGF at 10 min. The mean from three experiments with standard error is shown. The difference between the two conditions is insignificant (P > 0.05). (e) LDL uptake is not markedly affected by siRNA against ARFGAP1. BSC-1 cells were bound with fluorescently labelled LDL and assessed for the level of internalized LDL at 10 min. The mean from three experiments with standard error is shown. The difference between the two conditions is insignificant (P > 0.05). Uncropped images of blots are shown in Supplementary Fig. S6 . possible explanation. In our study, Tf was bound to the cell surface at 4 • C followed by washing to release nonspecific interactions. Cells were then warmed to 37 • C to restore transport. Importantly, we also quantified the level of internalized Tf. In contrast, the previous study incubated cells with Tf continuously at 37 • C, and then assessed Tf uptake qualitatively, by visual inspection 24 . When we carried out the Tf uptake assay by continuous incubation at 37 • C, we could still detect inhibition in Tf uptake induced by siRNA against ARFGAP1, by quantifying the level of internalized Tf ( Supplementary  Fig. S1b ). We sought further confirmation for our results using short hairpin RNA (shRNA) that targeted a different sequence in ARFGAP1 ( Supplementary Fig. S1c ). Inhibition of Tf uptake was again observed ( Supplementary Fig. S1d ), and was further characterized by kinetic analysis ( Supplementary Fig. S1e ).
We considered the possibility that the inhibition of Tf uptake following the depletion of ARFGAP1 could be an indirect effect of having perturbed COPI transport that acts in the secretory pathway. To address this issue, we initially explored whether ARFGAP1 interacted differently with AP-2 versus coatomer. When different truncation mutants of GST-ARFGAP1 were incubated with cytosol, we found that coatomer bound to the extreme carboxy-terminal region of ARFGAP1 (residues 401-415; Fig. 2a and Supplementary Fig. S2a ). In contrast, AP-2 and clathrin interacted with a more proximal region of ARFGAP1 (residues 301-400; Fig. 2b ). Within this region of ARFGAP1, we noted multiple tryptophan-based (WXXF/W) motifs ( Supplementary  Fig. S2b ), which mediate the binding of auxiliary proteins to AP-2 (refs 25,26) . Thus, we examined the effect of mutating residues within these motifs. One set of mutations involved substitutions at the second position of each motif (E330N/D364A/E383N; the triple mutant is referred to as EDE), which reduced the binding of ARFGAP1 to clathrin, but not to AP-2 ( Fig. 2c ). Another set of mutations involved substitutions at the fourth position in each motif (F332A/W366A/W385A; the triple mutant is referred to as FWW), which reduced the binding of ARFGAP1 to both AP-2 and clathrin ( Fig. 2d ). ARFGAP1 binding to coatomer was unaffected by either set of triple point mutations ( Fig. 2c,d ). Thus, these results revealed distinct requirements for the binding of ARFGAP1 to AP-2 and clathrin versus coatomer (summarized in Fig. 2e ).
We next determined whether ARFGAP1 could interact directly with AP-2 and clathrin using purified components. This approach revealed that ARFGAP1 interacted directly with AP-2 ( Fig. 3a ), but not with clathrin ( Fig. 3b ). Sequential incubations revealed that ARFGAP1 could interact with clathrin when AP-2 was first incubated with ARFGAP1 ( Fig. 3c ). We also found that the FWW mutation in ARFGAP1 reduced its direct interaction with AP-2, whereas the EDE mutation had a milder effect (Fig. 3a ). The EDE mutation in ARFGAP1 reduced the ability of AP-2 to link ARFGAP1 to clathrin, as assessed by sequential incubations of AP-2 followed by clathrin ( Fig. 3c ). These results revealed that ARFGAP1 could interact directly with the AP-2 adaptor and only indirectly with the clathrin triskelion.
Next, we investigated whether ARFGAP1 acted in AP-2 transport independently of its role in COPI transport. Cells were depleted of ARFGAP1 to inhibit Tf uptake, and then the different mutant forms of ARFGAP1 were assessed for their ability to rescue this defect. These experiments were carried out by transfecting the rat form of ARFGAP1, which is resistant to the targeting sequences used to deplete endogenous ARFGAP1 in primate cells. The two mutant forms of ARFGAP1 (FWW and EDE), which were found in the binding studies to have reduced ability to form a complex with AP-2 and clathrin, could not rescue defective Tf uptake ( Fig. 3d ). In contrast, wild-type ARFGAP1 and a truncated form, which spanned residues 1-400 and was defective for coatomer binding, did rescue this defect ( Fig. 3d ). We also assessed whether the different mutations in ARFGAP1 affected retrograde COPI transport. A chimaeric COPI cargo protein consisting of the KDEL (Lys-Asp-Glu-Leu) receptor coupled to a temperature-sensitive form of the vesicular stomatitis virus G protein, VSVG-ts045-KDELR, had been generated to track this transport in vivo 27 . At the non-permissive temperature, the misfolding of VSVG-ts045 prevents the chimaera from exiting from the endoplasmic reticulum. Thus, because the KDELR cycles between the endoplasmic reticulum and the Golgi, inhibition of its anterograde transport allows the unambiguous tracking of its retrograde transport, which is COPI dependent 28, 29 . We found that the ARFGAP1 mutant that could not interact with coatomer (1-400) also could not rescue defective retrograde COPI transport induced by the depletion of endogenous ARFGAP1 (Fig. 3e ). In contrast, the wild-type and the two mutant proteins that were defective in forming a complex with AP-2 and clathrin rescued this defect ( Fig. 3e ). Thus, the results of the rescue revealed that ARFGAP1 acted in AP-2 transport independently of its role in COPI transport.
Surveying transport pathways that require ARFGAP1
The surface level of the transferrin receptor (TfR) is predicted to represent the balance between its rates of endocytosis and recycling. We found that TfR surface levels were not appreciably altered by the depletion of ARFGAP1 ( Fig. 4a ), which indicated that TfR recycling would also be affected by the perturbation of ARFGAP1 levels. We confirmed this by examining TfR recycling directly ( Fig. 4b ). To determine whether this inhibition was an indirect effect of having suppressed TfR endocytosis, we again used the ARFGAP1 mutants that were defective in binding to the AP-2 complex. These mutants were able to rescue the defective TfR recycling that had been induced by the depletion of endogenous ARFGAP1 (Fig. 4c ), indicating that ARFGAP1 acts distinctly in TfR endocytosis versus recycling. In light of this finding, we next conducted a broader survey to determine whether ARFGAP1 could be acting in additional transport pathways.
Besides recycling to the plasma membrane, endocytic cargoes are transported towards two other general destinations, the lysosomes or the Golgi. To survey endocytic transport to lysosomes, we tracked dextran, a fluid-phase marker, which also allowed us to examine pinocytosis, a type of non-clathrin endocytosis 30 . We found that the internalization of dextran from the plasma membrane to early endosomes ( Supplementary Fig. S3a ), followed by its subsequent transport to lysosomes ( Supplementary Fig. S3b ), were not appreciably Figure 3 Disrupting the interaction between ARFGAP1 and either coatomer or AP-2 leads to selective disruption in transport pathways. (a) Pulldown assays to assess direct binding of ARFGAP1 to AP-2. Different forms of GST-ARFGAP1 were bound to beads, incubated with purified AP-2 adaptors and immunoblotted for the indicated proteins. GST fusion proteins were detected by Coomassie blue staining. (b) Pulldown assays to assess direct binding of ARFGAP1 to clathrin. The different forms of GST-ARFGAP1 were bound to beads, incubated with purified clathrin triskelia and immunoblotted for the indicated proteins. GST fusion proteins were detected by Coomassie blue staining. (c) Sequential incubations reveal that the AP-2 adaptor is needed to link ARFGAP1 to the clathrin triskelion. Different forms of GST-ARFGAP1 were bound to beads, and incubated with purified AP-2 followed by incubation with purified clathrin. Beads were analysed by immunoblotting for the indicated proteins. GST fusion proteins were detected by Coomassie blue staining. (d) Rescue of defective Tf uptake induced by the depletion of ARFGAP1. BSC-1 cells stably expressing shRNA against ARFGAP1 were transfected with the different forms of rat ARFGAP1 as indicated, and uptake of biotin-Tf at 10 min was quantified. The mean from three experiments with standard error is shown. The differences among conditions of ARFGAP1 shRNA, FWW and EDE are not significant (P > 0.05). The difference between this group and all other conditions is significant (P < 0.05). (e) Rescue of defective COPI transport induced by the depletion of ARFGAP1. BSC-1 cells stably expressing shRNA against ARFGAP1 were transfected with the different forms of rat ARFGAP1 as indicated. The redistribution of VSVG-KDELR from the Golgi to the endoplasmic reticulum at 30 min was then quantified. The mean from three experiments with standard error is shown. The differences among conditions of wild type, FWW and EDE are not significant (P > 0.05). The difference between this group and conditions of shARFGAP1 and 1-400 is significant (P < 0.05). Uncropped images of blots are shown in Supplementary Fig. S6 .
altered. To survey endocytic transport to the Golgi, we tracked the B subunit of cholera toxin (CTB), which also allowed us to examine raft-dependent internalization, another type of non-clathrin endocytosis 30 . We found that the internalization of CTB from the plasma membrane to early endosomes ( Supplementary Fig. S3c ), followed by subsequent transport to the trans-Golgi network (TGN; Supplementary Fig. S3d ), were also unaffected. Thus, ARFGAP1 did not have widespread roles in endocytic pathways. We next surveyed the secretory pathway by tracking a wellcharacterized anterograde cargo, VSVG-ts045 (refs 31,32) . Transport of this cargo from the endoplasmic reticulum to the TGN was slowed down in ARFGAP1-depleted cells ( Fig. 4d ). However, transport from the endoplasmic reticulum to the cis side of the Golgi (Fig. 4e ) and from the TGN to the plasma membrane was unaffected ( Fig. 4f ). Taken together, these results suggest that only the intra-Golgi segment of the secretory pathway was delayed by the depletion of ARFGAP1, as would be predicted by its role in COPI transport. Depletion of ARFGAP1 had minimal effects on Golgi structure, as assessed at the level of both light ( Supplementary Fig. S4a ) and electron ( Supplementary  Fig. S4b ) microscopy. Notably, similar findings had been observed by perturbing other critical components of COPI vesicle formation, such as brefeldin-A ADP-ribosylated substrate 28 (BARS) and phospholipase D2 (PLD2; ref. 29) . In contrast, perturbation of coatomer 33 or ARF1 (ref. 34 ) was previously observed to disrupt Golgi structure. Thus, we concluded that ARF1 and coatomer, as well as having a role in COPI vesicular transport, could have additional functions that make them critical for Golgi structure.
ARFGAP1 promotes cargo sorting by AP-2
To gain further insight into how ARFGAP1 could be acting in AP-2 transport, we determined its localization with respect to clathrin-coated pits. Using the conventional approach of confocal microscopy, we found that the Golgi pool of ARFGAP1 emitted a sufficiently strong fluorescence signal to hamper the ability to detect the peripheral pool of ARFGAP1. We therefore used total internal reflection fluorescence microscopy (TIR-FM) with live-cell imaging. We confirmed that ARFGAP1 was still functional when coupled to the green fluorescent protein (GFP), as the fusion protein could still rescue the inhibition of Tf uptake induced by the depletion of ARFGAP1 ( Supplementary  Fig. S5a ). Using TIR-FM, we detected ARFGAP1 in clathrin-coated depletion. An antibody that recognizes the extracellular domain of TfR was bound to BSC-1 cells, followed by quantification. The mean from three experiments with standard error is shown. The difference between the two conditions is insignificant (P > 0.05). (b) TfR recycling is reduced by siRNA against ARFGAP1. BSC-1 cells were treated with siRNA against ARFGAP1 and the level of internal biotin-Tf was quantified at the indicated time points. The mean from three experiments with standard error is shown. The difference between the two conditions (except time = 0) is significant (P < 0.05). (c) Rescue of defective TfR recycling induced by the depletion of ARFGAP1. BSC-1 cells stably expressing shRNA against ARFGAP1 were transfected with the different forms of rat ARFGAP1 indicated. The level of internal biotin-Tf that remained after 10 min of recycling was then quantified. The mean with standard error from three experiments is shown. The difference between cells expressing ARFGAP1 shRNA and all other conditions is significant (P < 0.05). (d) Depletion of ARFGAP1 inhibits transport from the endoplasmic reticulum to the TGN. VSVG-ts045-GFP was transfected into BSC-1 cells, followed by quantification of its co-localization with a TGN marker (TGN46). The mean from three experiments with standard error is shown. The difference at all time points is significant (P < 0.05). (e) Depletion of ARFGAP1 does not affect transport from the endoplasmic reticulum to the cis side of the Golgi. VSVG-ts045-GFP was transfected into BSC-1 cells, followed by quantification of its co-localization with a cis -Golgi marker (giantin). The mean from three experiments with standard error is shown. The difference at all time points is insignificant (P > 0.05). (f) Depletion of ARFGAP1 does not affect transport from the TGN to the plasma membrane (PM). VSVG-ts045-GFP was transfected into BSC-1 cells, and then accumulated at the TGN. Cells were then shifted from 20 to 32 • C to allow transport to the plasma membrane. Arrival of VSVG at the plasma membrane was detected through co-localization with fluorescently labelled CTB (which was bound to the cell surface). The mean from three experiments with standard error is shown. The difference at all time points is insignificant (P > 0.05). pits ( Fig. 5a ). Dynamic imaging revealed that ARFGAP1 associated transiently with clathrin-coated structures mainly at the later stage of their lifetime (Fig. 5b ).
Using quantitative electron microscopy, we found that the level of coated pits was reduced in cells depleted of endogenous ARFGAP1 (Fig. 5c ). Thus, as coated pits internalize a broad range of cargoes 13 , a prediction was that ARFGAP1 would be important for the endocytosis of more cargoes than just that TfR. Supporting this prediction, we found that the endocytosis of cystic fibrosis transmembrane conductance regulator (CFTR), which requires AP-2 (ref. 35) , was also inhibited by the depletion of ARFGAP1 (Fig. 5d ). We next examined whether the depletion of ARFGAP1 arrested a particular stage of coated-pit formation. However, no particular stage was observed to accumulate ( Fig. 5e ). To account for the above observations, we were led by a recent study that showed clathrin vesicle formation can have two general outcomes, either productive or abortive 36 . As cargoes have been shown recently to promote the productive fate [36] [37] [38] , we next explored whether ARFGAP1 promoted cargo binding by AP-2.
Studying TfR as the model cargo, we initially determined whether an in vivo complex between ARFGAP1 and surface TfR and AP-2 could be detected. To examine only endogenous proteins, biotin-conjugated Tf was bound to the cell surface, and following cell lysis, lysates were incubated with streptavidin-bound beads. Surface TfR was found to be associated with AP-2 and ARFGAP1 ( Fig. 6a ). Transfected GFP-tagged ARFGAP1 similarly associated with surface TfR and AP-2 ( Fig. 6b ), which supported our previous observation that this tagged ARFGAP1 could be detected in coated pits. In contrast, two other ARFGAPs, ARFGAP2 and ARFGAP3, could not interact with surface TfR (Fig. 6c ). Moreover, consistent with our initial finding that the endocytosis of the LDL receptor (LDLR) was not affected by the depletion of ARFGAP1, we found that a surface form of this receptor (CD8-LDLR), previously used study the endocytosis of LDLR, (ref. 23) did not interact with ARFGAP1 ( Fig. 6d ). Previous studies had observed variable effects on LDL uptake following the depletion of AP-2, with no inhibition detected by the traditional method of uptake (which involved binding at 4 • C followed by incubation at 37 • C; ref. 23 ), whereas inhibition was detected by an alternative method (which involved continuous uptake at 37 • C; ref. 39) . In contrast, we found that the depletion of ARFGAP1 inhibited Tf uptake using either method (see Fig. 1c and Supplementary S1b). Thus, these observations confirm the specificity by which ARFGAP1 functions in the endocytosis of TfR.
Cargo sorting involves coat components binding directly to sorting signals in cargo proteins 1, 13 . Thus, we examined whether ARFGAP1 could interact directly with two internalization sorting signals that had been identified in the cytoplasmic domain of TfR. One signal requires a critical phenylalanine at position 13 of TfR, whereas the other requires HeLa cells were treated with the indicated siRNA conditions. All forms of clathrin-coated (CC) intermediates were counted and then divided by the length of the plasma membrane. Seven cells were randomly selected from each condition to obtain the mean with standard deviation. The difference between the two conditions is significant (P < 0.05). (d) Depletion of ARFGAP1 inhibits the endocytosis of CFTR. CFBE41o-cells expressing wild-type CFTR were polarized and treated with the indicated siRNA conditions. The level of internalized CFTR was then quantified. The mean with standard error from three experiments is shown. The difference between the two conditions (except time = 0) is significant (P < 0.05). (e) Depletion of ARFGAP1 does not induce accumulation of a particular stage of coated pit. The different stages of coated-pit formation, with representative images for each stage shown (left; bar, 100 nm), were detected by electron microscopy, and then quantified. The mean from three experiments with standard deviation is shown (right). The difference between corresponding stages is insignificant (P > 0.05).
a critical 'YTRF' motif (positions 20-23; refs 40,41). We generated a series of truncation constructs that encompassed the cytoplasmic domain of TfR (summarized in Supplementary Fig. S5b ), and found that ARFGAP1 bound to the portion of the TfR cytoplasmic region that contained both internalization sorting signals (Fig. 7a ). Subsequently, examining truncations of TfR that possessed either of these two sorting signals, we found that ARFGAP1 could bind to either signal (Fig. 7b) .
In contrast, AP-2 could bind only to the sorting signal defined by the 'YTRF' motif ( Fig. 7c ). We also examined how mutations at the two sorting signals of TfR affected its association with ARFGAP1 and AP-2 in vivo. TfR forms homodimers 42 , so a transfected mutant TfR could potentially pair with endogenous wild-type TfR and thereby mask an effect of a particular mutation. To overcome this potential hurdle, we used a mutant cell line that lacked endogenous TfR (ref. 41) . When different forms of TfR were transfected into this cell line, mutations in one sorting signal (containing the 'YTRF' motif) abrogated the association of TfR with AP-2 and ARFGAP1 more strongly than mutations in the other sorting signal (Fig. 7d) . Notably, we also found that the depletion of ARFGAP1 reduced the association of AP-2 with TfR in vivo (Fig. 7e) . Taken together, the binding results suggested that ARFGAP1 acted in promoting cargo sorting by AP-2.
Elucidating the role of the GAP activity in TfR endocytosis
As ARFGAP1 also possessed a GAP activity, we next examined whether this had a role in AP-2 transport. A point mutation in ARFGAP1 had been shown previously to abrogate its GAP activity 43 . Whereas wild-type ARFGAP1 could rescue the defective Tf uptake induced by the depletion of endogenous ARFGAP1, the catalytic-dead mutant could not ( Fig. 8a and Supplementary Fig. S5c ). This result not only revealed a role for the GAP activity of ARFGAP1 in AP-2 transport, but also implicated an ARF in this process. Consistent with ARF6 having been (a) Endogenous surface TfR interacts with endogenous forms of ARFGAP1 and AP-2 in vivo. Biotin-labelled Tf was bound to the surface of HeLa cells, followed by isolation using streptavidin beads and then immunoblotting for the indicated proteins. (b) GFP-tagged ARFGAP1 associates with endogenous forms of surface TfR and AP-2. BSC-1 cells were transfected with GFP-tagged ARFGAP1. Cells were then bound with biotin-labelled Tf, followed by incubation of cell lysate with streptavidin beads and immunoblotting for the indicated proteins.
(c) Surface TfR does not associate with ARFGAP-2 or ARFGAP3. HeLa cells were transfected with Myc-tagged ARFGAP1, or (HA)-tagged forms of ARFGAP-2 or ARFGAP3. Cells were bound with biotin-labelled Tf. Cell lysis was followed by incubation of cell lysate with streptavidin beads and immunoblotting for the indicated proteins. ARFGAPs were detected using antibodies against the epitope tag. (d) A surface form of LDLR does not associate with ARFGAP1. HeLa cells stably expressing CD8-LDLR were incubated with anti-CD8 antibody. After this surface binding, cells were lysed and incubated with protein A beads, followed by immunoblotting for the indicated proteins. Uncropped images of blots are shown in Supplementary Fig. S7 .
suggested to act in clathrin-mediated endocytosis [44] [45] [46] , the depletion of ARF6 inhibited Tf uptake (Fig. 8b) . The GAP activity of ARFGAP1 had only been well documented to act on ARF1. Thus, we revisited the in vitro GAP assay, and found that ARF6 could also be a substrate ( Supplementary Fig. S5d ). Furthermore, as coatomer had been shown to stimulate the GAP activity of ARFGAP1 towards ARF1 (ref. 47) , we found that AP-2 could also stimulate the GAP activity of ARFGAP1 towards ARF6 (Fig. 8c ).
On seeking further insight into how the GAP activity of ARFGAP1 acted in TfR endocytosis, we initially found that ARF6 could bind directly to the cytoplasmic domain of TfR in an activation-dependent manner (Fig. 8d ). Moreover, ARF6 synergized with ARFGAP1 in enhancing the binding of AP-2 to TfR (Fig. 8e) . Notably, the GAP activity of ARFGAP1 further enhanced this binding. This was suggested by the observation that ARF6 preloaded with GTP allowed better binding of TfR by AP-2 than ARF6 loaded with a non-hydrolysable analogue of GTP (GTP-γS; Fig. 8e ). As confirmation, we found that the activation-dependent binding of ARF6 to TfR was abrogated when ARFGAP1 was added to the incubation, whereas this effect was prevented when ARF6 was preloaded with GTP-γS ( Fig. 8f ). We also sought in vivo confirmation for key aspects of these in vitro findings. First, we confirmed that ARF6 bound to TfR in an activation-dependent manner, as the activating (Q67L), but not the deactivating (T27N), point mutant of ARF6 associated with surface TfR (Fig. 8g ). Second, we confirmed that ARF6 deactivation was important for the binding of AP-2 to surface TfR in vivo, as the expression of ARF6 Q67L reduced this association (Fig. 8h ). Altogether, these results suggested that at least one mechanism by which the GAP activity of ARFGAP1 promoted TfR endocytosis involved the optimization of cargo binding by AP-2.
DISCUSSION
We have found that ARFGAP1 promotes AP-2-dependent endocytosis. Characterizing this role, we have uncovered mechanistic parallels to the previously reported roles of ARFGAP1 in COPI transport, which involve functions as both an ARF effector and regulator 6 . ARFGAP1 binds to the two known sorting signals in TfR to promote endocytosis. Moreover, ARFGAP1 is needed to link AP-2 to TfR. These observations suggest that ARFGAP1 behaves as an ARF effector by acting as an auxiliary coat component to promote cargo sorting by AP-2. We have also found that ARFGAP1 acts as an ARF6 regulator in AP-2 transport, as activated ARF6 that binds to TfR must be deactivated by the GAP activity of ARFGAP1 to allow optimal binding of TfR by AP-2.
AP-2 is now appreciated to act in at least two distinct stages. An initial stage involves AP-2 engaging a critical lipid, phosphatidylinositol 4,5-bisphosphate (PIP2), on the plasma membrane. A later stage involves AP-2 subsequently undergoing major conformational changes to open its binding sites for cargoes 48, 49 . ARF6 has been shown to promote PIP2 production 44, 50 . As such, it is predicted to act in the early stage of AP-2 action. However, our elucidation of how the GAP activity of ARFGAP1 promotes TfR endocytosis suggests an additional role for ARF6. This role is predicted to occur in the later stage of AP-2 action, which involves a complete GTPase cycle of ARF6 that optimizes cargo binding by AP-2. ARF1 deactivation has been shown to promote COPI cargo sorting 51 , but the underlying mechanism has been unclear. As the mechanistic action of ARFGAP1 is similar in both AP-2 and COPI transport, our present elucidation of how the GAP activity of ARFGAP1 promotes AP-2 cargo sorting also provides insights into its function in COPI cargo sorting. (a) Pulldown assays were carried out in which the indicated TfR constructs were incubated with recombinant ARFGAP1, followed by immunoblotting for ARFGAP1. GST fusion proteins were detected by Coomassie blue staining. (b) Pulldown assays were carried out in which the indicated TfR constructs were incubated with recombinant ARFGAP1, followed by immunoblotting for ARFGAP1. GST fusion proteins were detected by Coomassie blue staining. Point mutations within particular truncation constructs are indicated within parentheses. (c) Pulldown assays were carried out in which the indicated TfR constructs were incubated with purified AP-2, followed by immunoblotting for β2-adaptin. GST fusion proteins were detected by Coomassie blue staining. Point mutations within particular truncation constructs are indicated within parentheses.
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(d) Effects of TfR mutations on its association with ARFGAP1 and AP-2. Biotin-labelled Tf was bound to the surface of mutant CHO (TRVb) cells expressing different full-length TfR forms (wild type or with the indicated point mutations) followed by isolation using streptavidin beads and immunoblotting for the proteins indicated. The '4A' construct contains alanine substitutions at residues 12, 13, 22 and 23 of TfR.
(e) Association of surface TfR with AP-2 requires ARFGAP1. BSC-1 cells were treated with siRNA against ARFGAP1. Biotin-labelled Tf was bound to the surface of BSC-1 cells, followed by isolation using streptavidin beads and immunoblotting for the endogenous proteins indicated. Cell lysates were also directly immunoblotted for proteins in the indicated conditions. Uncropped images of blots are shown in Supplementary  Fig. S7 . BSC-1 cells were treated with siRNA against ARF6 and uptake of biotin-Tf at 10 min was quantified. The mean with standard error from three experiments is shown. The difference between the two conditions is significant (P < 0.05).
(c) AP-2 enhances GAP activity of ARFGAP1 towards ARF6. The GAP assay was carried out using ARF6 as the substrate, and either with (triangles) or without (squares) AP-2. The mean from three experiments with standard error is shown. (d) Binding of ARF6 to TfR is activation dependent. The functional activation of ARF6 was confirmed using the effector domain of GGA3 (Golgi-localized, γ-adaptin ear-containing, ARF-binding protein 3)
in a pulldown experiment (left panel). ARF6 forms were also incubated with GST-TfR in another pulldown experiment (right panel). (e) GAP activity of ARFGAP1 optimizes the binding of AP-2 to TfR. GST-TfR was incubated sequentially with ARF6 (containing different bound nucleotides, as indicated), followed by ARFGAP1 and then AP-2. (f) Deactivation of ARF6 by ARFGAP1 releases ARF6 from binding to TfR. ARF6 loaded with GTP forms, as indicated, were incubated with GST-TfR along with ARFGAP1 in a pulldown experiment. (g) Activation-dependent binding of ARF6 to surface TfR. BSC-1 cells were transfected with point-mutant forms of ARF6 as indicated. Surface TfR was isolated through biotin-Tf binding to cell surface, followed by incubation with streptavidin beads and immunoblotting was carried out for the indicated proteins. (h) The constitutively activated form of ARF6 (Q67L) reduces the binding of AP-2 to surface TfR. BSC-1 cells were transfected with ARF6 Q67L or mock transfected. Surface TfR was isolated as described in g, followed by immunoblotting for the indicated associated proteins. Uncropped images of blots are shown in Supplementary  Fig. S8 .
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METHODS Proteins and antibodies. GST fusion and 6×-His-tagged recombinant proteins were purified as previously described 19 . AP-2 and clathrin were purified as previously described 52 . Alexa 546-conjugated Tf, Alexa 555-EGF, Dil-LDL and Alexa 555conjugated forms of dextran and CTB were obtained (Invitrogen).
The following antibodies were used, with dilution and source as indicated. Antibodies against the following proteins have been described previously 28, 53 : ARF6 (1:200), ARFGAP1 (1:1,000), BARS (1:2,000), β2-adaptin (AP.6, 1:5,000), β-COP (M3A5, 1:100, or culture supernatant, 1:10), CHC (TD.1, 1:500, or culture supernatant, 1:30), giantin (1:5,000), Lamp1 (1:500), Myc epitope (9E10, 1:1,000), TfR (5E9, 1:500, or H68.4, 1:1,000) and VSVG (BW8G65, culture supernatant 1:10). Antibodies against other proteins were obtained: CD8 (1:400, Santa Cruz), EEA1 (1:200, BD Bioscience), HA epitope (HA.11, 1:1,500, Covance) and TGN46 (1:1,000, AbD Serotec).
Mass spectrometry.
Cytosol was purified from rat brains by initially homogenizing them in buffer B (25 mM Tris at pH 8, 500 mM KCl, 250 mM sucrose, 2 mM EGTA, 1 mM dithiothreitol (DTT) plus protease inhibitors) at 4 • C, followed by centrifugation at 5,000g for 30 min and then 150,000g for 90 min. The resulting supernatant was dialysed against buffer C (25 mM Tris at pH 8, 50 mM KCl and 1 mM DTT), followed by centrifugation at 150,000g for 90 min at 4 • C, and then stored at −80 • C. GST-ARFGAP1 was crosslinked to glutathione sepharose by washing with sodium borate, incubation with dimethyl pimelimidate (DMP) for 30 min followed by two washes with ethanol amine at pH 8.2 and two washes with 0.1 M glycine at pH 2.5. Beads were then incubated with or without 10 mg rat brain cytosol for 4 h followed by extensive washing. Samples were separated by SDS-PAGE and then stained with silver chloride. Specific bands were excised for analysis by mass spectrometry (MSF facility, University of California, San Francisco, USA).
Plasmids, mutagenesis and RNA interference. Constructs encoding for mutant
forms of rat ARFGAP1 fused to GST were generated by PCR, digested with EcoRI (for forward primers) or XhoI (for reverse primers) and inserted into the pGEX-6P1 vector (Amersham) using the Rapid ligation kit (Promega). Site-directed mutagenesis was carried out with the QuikChange site-directed mutagenesis kit (Stratagene), and then verified by sequencing. Multi-site mutagenesis PCR was carried out by addition of Taq ligase (New England Biolabs), 0.5× ligase buffer and mutant primers annealing only to the lower DNA strand. All constructs were verified by DNA sequencing (MWG Biotech). Other constructs have been previously described, including ARFGAP1-Myc (ref. 20) , mutant forms of the TfR cytoplasmic domain as GST fusion constructs 54 , VSVG-KDELR tagged with yellow fluorescent protein 29 (YFP) and clathrin light chain tagged with mCherry 36 . Additional constructs were obtained: GFP-ARFGAP1 (gift from D. Cassel, Technion, Israel), and VSVG-ts045-GFP and VSVG-ts045-KDELR (J. Lippincott-Schwartz, NIH, USA).
Nucleotides 206-224 of human ARFGAP1 were targeted for siRNA (5 -ACAUUGAGCUUGAGAAGAU-3 ; Dharmacon), and nucleotides 297-318 of human ARFGAP1 were targeted for shRNA (5 -ACAGGAGAAGUACAACAGCAGA-3 ; Thermal Scientific). A lentivirus expression system (Thermal Scientific) was used for the stable expression of shRNA in BSC-1 cells.
Transfections. FuGene 6 (Roche) was used to transfect DNA plasmids, and Oligofectamine (Invitrogen) or Lipofectamine RNAiMax (Invitrogen) was used to transfect siRNA oligonucleotides, all according to manufacturers' guidelines.
Pulldown assays. GST fusion proteins on glutathione beads were incubated with soluble proteins (4-10 nM) at 4 • C for 1 h in 0.5 ml of a buffer that contained 50 mM HEPES (at pH 7.3), 300 mM NaCl, 90 mM KCl, 1 mM EDTA and 0.5% NP-40. After this incubation, beads were pelleted by centrifugation (1000g for 1 min at 4 • C) followed by two washes with the incubation buffer and then analysed by SDS-PAGE followed by western blotting. Coomassie blue staining was carried out to detect the level of GST fusion proteins on beads. In experiments that assessed how GAP activity modulates the binding of AP-2 to TfR, a modified buffer was used (to allow more efficient GAP activity), which contained 50 mM HEPES (at pH 7.3), 300 mM NaCl, 90 mM KCl, 1 mM MgCl 2 and 0.5% NP-40.
In vivo assays. To detect proteins associated with surface TfR, intact cells were initially bound by biotin-labelled Tf at 4 • C. Cells were then lysed followed by incubation with beads coated with streptavidin. Beads were then washed and loaded onto SDS-PAGE gel followed by immunoblotting.
Tf, EGF and LDL uptake assays were carried out using a fluorescence-based approach, as previously described 32 . Tf uptake was also quantified by a biochemical approach. Briefly, biotin-conjugated Tf was bound to intact cells at 4 • C, followed by washing with DMEM/PBS to release nonspecific binding. Cells were then warmed to 37 • C to initiate endocytosis for the times indicated. Cells were then washed with ice-cold DMEM/PBS to arrest transport, followed by washes with an acid-based buffer (0.5 M NaCl and 0.5% acetic acid) to release biotin-Tf that remained bound to the cell surface. Cells were then lysed followed by SDS-PAGE analysis, and then detection with horseradish peroxidase (HRP)-conjugated streptavidin. The level of internalized biotin-Tf was normalized to that initially bound to the cell surface in calculating the fraction of TfR internalized.
TfR recycling was carried out by first incubating biotin-conjugated Tf with cells at 37 • C for 2 h. Cells were then shifted to 4 • C for washes with an acid-based buffer (0.5 M NaCl and 0.5% acetic acid) to release biotin-Tf that remained bound to the cell surface. To measure recycling, cells were then warmed to 37 • C to restore transport, followed by another acid-wash. Cells were then lysed followed by SDS-PAGE analysis, and then detection with HRP-conjugated streptavidin. For quantification, the level of internal biotin-Tf was normalized to the level of biotin-Tf within cells at the start of recycling to calculate the fraction of internal Tf remaining at different time points.
To assess transport from the plasma membrane to the early endosome, and subsequently to the lysosome, fluorescently labelled dextran was incubated with cells at 37 • C for the times indicated. Co-localization was then carried out with markers of the early endosome (EEA1) and the lysosome (Lamp1). To assess transport from the plasma membrane to the early endosome, and subsequently to the TGN, fluorescently labelled CTB was bound to the cell surface at 4 • C. Cells were then washed with PBS, followed by warming to 37 • C for the times indicated. Co-localization was then carried out with markers of the early endosome (EEA1) and the TGN (TGN46). Confocal images were obtained using an inverted microscope (TE2000, Nikon) with a C1 confocal system. Quantification of co-localization was carried out as previously described 53 .
Other in vivo transport assays have been described, including anterograde transport of VSVG-ts045 (ref. 55 ) and the redistribution of VSVG-ts045-KDELR from the Golgi to the endoplasmic reticulum to assess retrograde COPI-dependent transport 29 . Endocytosis of surface CTFR in polarized CFBE41o cells has also been described previously 56 . In particular, polarized monolayers were cultured to attain a resistance of ∼400 cm 2 , which typically occurred after 4 days.
In vitro GAP assay. This assay was carried out essentially as previously described 57 .
Briefly, large unilamellar vesicles consisting of 40% phosphatidylcholine, 25% phosphatidylethanolamine, 15% phosphatidylserine, 10% phosphatidylinositol and 10% cholesterol (Avanti Polar Lipids) were prepared by extrusion. Recombinant ARF1 or ARF6 was loaded with [α-32 P]GTP at 30 • C for 30 min in the presence of large unilamellar vesicles with 500 µM lipid in the GTP loading buffer (25 mM HEPES, at pH 7.4, 100 mM NaCl, 0.5 mM MgCl 2 , 1 mM EDTA, 1 mM ATP and 1 mM DTT). GTP hydrolysis was initiated by adding recombinant ARFGAP1 at different concentrations, either with or without AP-2 (175 nM), to [α-32 P]GTPloaded ARF6 (1 µM) in GAP assay buffer (25 mM HEPES, at pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 1 mM GTP and 1 mM DTT).
Electron microscopy. Cells grown on 35-mm glass-bottom dishes (
MatTek corporation) were fixed with 1% glutaraldehyde in 100 mM HEPES at pH 7.4 overnight, washed several times with 100 mM HEPES at pH 7.4, once with double-distilled water and post-fixed with 1% OsO 4 , 1.5% Na 4 Fe(CN) 6 in 0.1 M cacodylate buffer at pH 7.4 for 1 h at room temperature. Samples were washed with double-distilled water, dehydrated with ethanol and embedded in Epon. Serial sections were counterstained with 1% lead citrate and then observed by electron microscopy. Quantification of coated pits was carried out on random images taken at ×43,000 magnification.
Live-cell imaging by TIR-FM.
Live-cell imaging experiments were carried out using BSC-1 cells transiently expressing GFP-ARFGAP1 together with clathrin light chain A-mCherry. At 48 h post-transfection, the cells were plated on 25-mmdiameter glass coverslips (#1.5, Warner Instruments), allowed to spread for 3 h and then imaged. The coverslips were then washed with sterile PBS and immediately placed into an open perfusion chamber into which pre-warmed Minimum Essential Medium alpha without phenol red (GIBCO) was then added. The chamber was inserted into a temperature-controlled sample holder (20/20 Technology) and then placed on the microscope stage enclosed by an environmental chamber (37 • C). The cells were always kept in humidified 5% CO 2 . TIR-FM imaging was carried out using a Mariana system (Intelligent Imaging Innovations) based on a 200 M inverted microscope (Zeiss) and a TIRF slider with manual angle control 58 (Zeiss). Fluorescent images were acquired with an oil immersion Alpha Plan-Apo ×100 objective (1.46 NA). Solid-state lasers were used as sources of excitation light at 488 nm (Sapphire, 50 mW, Coherent Inc.) and 561 nm (Jive, 50 mW, Cobolt AB) coupled through an acousto-optical tunable filter into a single-mode fibre optic, carried to the TIRF slider and reflected towards the objective using a multi-band dichroic mirror (Di01-R405/488/561/635, Semrock). The fluorescence emission light was collected by the objective, then passed through the dichroic mirror and a multi-band emission filter (FF01-446/523/600/677, Semrock). A spherical aberration correction unit (Intelligent Imaging Innovations) was inserted Figure S1 Effects of depleting ARFGAP1. a. Depletion of ARFGAP1 by siRNA. BSC-1 cells were treated with a siRNA sequence that targeted primate ARFGAP1. Cells were lysed and then immunoblotted for proteins as indicated. b. An alternate assay for Tf uptake also reveals inhibition upon siRNA against ARFGAP1. BSC-1 cells were incubated continuously with Tf in medium at 37 o C. Quantitation was then performed. The mean with standard error from three experiments is shown. Difference between the two conditions is significant (p<0.05). c. Depletion of ARFGAP1 by shRNA. BSC-1 cells that stably expressed a shRNA sequence targeting another region in the primate ARFGAP1 were lysed, and then immunoblotted for proteins as indicated. d. Tf uptake is inhibited by shRNA against ARFGAP1. BSC-1 cells that stably expressed shRNA conditions as indicated were assayed for the uptake of biotin-Tf at 10 minutes, followed by quantitation. The mean from three experiments with standard error is shown. Difference between the two conditions is significant (p<0.05). e. Kinetics of Tf uptake upon siRNA against ARFGAP1. BSC-1 cells were treated with siRNA, followed by quantitation of Tf uptake at times as indicated. The mean from three experiments with standard error is shown. Difference between the two conditions (except time=0) is significant (p<0.05). Figure S3 Effect of depleting ARFGAP1 on endocytic pathways. a. Depletion of ARFGAP1 does not affect fluid-phase uptake followed by transport to the early endosome. Fluorescence-conjugated dextran was added to BSC-1 cells for times indicated, and then colocalization with an early endosome marker (EEA1) was quantified at times indicated. The mean from three experiments with standard error is shown. Difference at all time points is insignificant (p>0.05). b. Depletion of ARFGAP1 does not affect transport from the early endosome through the late endosome and then to the lysosome. Fluorescence-conjugated dextran was added to BSC-1 cells for times indicated, and then colocalization with a lysosomal marker (Lamp1) was quantified at times indicated. The mean from three experiments with standard error is shown. Difference at all time points is insignificant (p>0.05). c. Depletion of ARFGAP1 does not affect raftdependent endocytosis followed by transport to the early endosome. Fluorescence-conjugated cholera toxin B subunit (CTB) was added to BSC-1 cells for times indicated, and then colocalization with an early endosome marker (EEA1) was quantified at times indicated. The mean from three experiments with standard error is shown. Difference at all time points is insignificant (p>0.05). d. Depletion of ARFGAP1 does not affect transport from the early endosome to the TGN. Fluorescence-conjugated CTB was added to BSC-1 cells for times indicated, and then colocalization with a TGN marker (TGN46) was quantified at times indicated. The mean from three experiments with standard error is shown. Difference at all time points is insignificant (p>0.05). Rescue of defective Tf uptake by a GFP-tagged form of ARFGAP1. BSC-1 cells that stably expressed shRNA against ARFGAP1 were transfected with the rat form of GFP-tagged ARFGAP1. Uptake of biotin-Tf at 10 minutes was then quantified. The mean with standard error from three experiments is shown. Difference between shRNA and all other conditions is significant (p<0.05). b. Truncation forms of TfR used to assess direct binding by ARFGAP1 and AP-2. Critical phenylalanines that anchor the two distinct internalization sorting signals in TfR are indicated by arrowheads. c. Assessing efficiency of depleting ARFGAP1 and expression of different rescue constructs. Immunoblotting was performed on whole cell lysates to assess the level of proteins as indicated. d.
Comparison of GAP activity of ARFGAP1 toward ARF6 versus ARF1. The GAP assay was performed using ARF6 (triangles) or ARF1 (squares) as substrate. The mean from three experiments with standard error is shown. Coomassie staining Figure S8 
